The purpose of this guide is to ensure that the participants in our clinical studies accurately reflect the real-world population that is living with the condition we are studying. Understanding disease epidemiology and increasing accessibility to our clinical studies enables us to uphold scientific integrity, which ultimately improves the effectiveness and safety of treatments for all people living with the condition.

This guide was co-developed among PALADIN patient advocates and pharmaceutical company representatives.